The American Academy of Pain Medicine      Annual Meeting Home Page     
23rd Annual Meeting
February 7-10, 2007
New Orleans, LA

© 2006 American Academy of Pain Medicine
 


Thursday, February 8, 2007
141

How Well -Controlled is Sickle Cell Pain in the Community?

Arleen Anderson, Wendy Thompson, Stephen Tafor, and Ike Eriator. University of Mississippi, Jackson, MS, USA

A number of sickle cell patients manage a great deal of their pain episodes at home. This study sought to determine if provision of increased knowledge and skills in the use of pharmacologic and non-pharmacologic methods will provide sickle cell patients with greater self-management of pain, improved quality of life and decreased hospitalizations. Following IRB approval, a survey questionnaire for baseline data was administered to sickle cell patients at the sickle cell clinic at a major teaching institution serving the major regions of a state.

Analysis of 46 completed surveys revealed that the average age of respondents was 30 years of age and the majority were females (58.4%). 57.9% have a diagnosis of sickle cell anemia (hemoglobin SS), while 38.6% had hemoglobin SC disease, and 5% other hemoglobinopathies. About 22.2% of the respondents were taking potent opioids (narcotics) for pain control. About 44% reported experiencing mild-moderate pain events within the last 6 months. 60.0% had experienced moderate-severe pain requiring a visit to a medical facility within the past 6 months. More than 75% reported pain greater than 5 on a 0 – 10 point scale when asked to rate their pain during these events. Relaxation was reported as being used by 77.8% of respondents to help control pain, heating pad was used by 3.7%, and 14.81% report using other techniques to help manage pain events.

The data suggest that a significant number of people with sickle cell disease has significant pain and currently use a combination of pharmacological and non-pharmacological methods to manage pain events. There are opportunities for education and other interventions to improve such techniques and empower such patients to achieve improved pain control. As a corollary, this will decrease health care utilization and improve patients' well being and family life for this group of patients.


References: Chen, Edith, PhD, Cole, Steve, PhD, Kato, Pamela, PhD. A Review of Empirically Supported Psychosocial Interventions for Pain and Adherence Outcomes in Sickle Cell Disease. Journal of Pediatric Psychology 29(3) pp. 197-209, 2004.

Dampier, C., M.D., Ely, E., PhD, RN, Brodecki, D., O'Neal, P, A.A., Home Management of Pain in Sickle Cell Disease: A Daily Diary Study in Children and Adolescents. Journal of Pediatric Hematology/Oncology, Vol.24(8), Nov. 2002, pp 643-647

Maxwell, K., Streetly, A., Bevan, D., Experiences of Hospital Care and Treatment Seeking For Pain from Sickle Cell Disease: Qualitative Study. British Medical Journal, 1999;318;1585-1590.

Shaiova, L., M.D., Wallenstein, D., M.D., Outpatient Management of Sickle Cell Pain with Chronic Opioid Pharmacotherapy. Journal of the National Medical Association, vol. 96(7) July 2004 (case report)

Wang, W.C., Pain at Home in Sickle Cell Disease: An Underrecognized Problem. Journal of Pediatric Hematology/Oncology, Vol. 24(8), Nov. 2002 (Guest commentary)
Funding: Jackson Heart Study

Arleen Anderson
Nothing to disclose.